Guardant Health Inc - Asset Resilience Ratio
Guardant Health Inc (GH) has an Asset Resilience Ratio of 40.89% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Guardant Health Inc for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how Guardant Health Inc's Asset Resilience Ratio has changed over time. See what is Guardant Health Inc's book value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Guardant Health Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Guardant Health Inc (GH) market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $823.39 Million | 40.89% |
| Total Liquid Assets | $823.39 Million | 40.89% |
Asset Resilience Insights
- Very High Liquidity: Guardant Health Inc maintains exceptional liquid asset reserves at 40.89% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Guardant Health Inc Industry Peers by Asset Resilience Ratio
Compare Guardant Health Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Genetic Signatures Ltd
AU:GSS |
Diagnostics & Research | 57.28% |
|
Leveljump Healthcare Corp
V:JUMP |
Diagnostics & Research | 32.45% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
Sonic Healthcare Ltd
AU:SHL |
Diagnostics & Research | 0.13% |
|
Integral Diagnostics Ltd
AU:IDX |
Diagnostics & Research | 0.03% |
|
Australian Clinical Labs Ltd
AU:ACL |
Diagnostics & Research | 4.11% |
|
Healius Ltd
AU:HLS |
Diagnostics & Research | 0.06% |
|
Monash Ivf Group Ltd
AU:MVF |
Diagnostics & Research | 1.60% |
Annual Asset Resilience Ratio for Guardant Health Inc (2016–2025)
The table below shows the annual Asset Resilience Ratio data for Guardant Health Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 40.89% | $823.39 Million | $2.01 Billion | +19.72pp |
| 2024-12-31 | 21.17% | $314.44 Million | $1.49 Billion | +19.20pp |
| 2023-12-31 | 1.96% | $35.10 Million | $1.79 Billion | -52.05pp |
| 2022-12-31 | 54.01% | $869.58 Million | $1.61 Billion | +34.03pp |
| 2021-12-31 | 19.98% | $440.55 Million | $2.20 Billion | -22.36pp |
| 2020-12-31 | 42.34% | $961.90 Million | $2.27 Billion | +2.91pp |
| 2019-12-31 | 39.43% | $379.57 Million | $962.53 Million | -7.96pp |
| 2018-12-31 | 47.40% | $278.42 Million | $587.40 Million | +3.94pp |
| 2017-12-31 | 43.46% | $149.04 Million | $342.94 Million | -9.44pp |
| 2016-12-31 | 52.90% | $61.66 Million | $116.56 Million | -- |
About Guardant Health Inc
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tu… Read more